GoPath Diagnostics

✨ Warm wishes from GoPath! ✨ As we reflect on another year of growth and innovation, our hearts are filled with gratitude for everyone who helped shape our journey—our incredible clients, dedicated partners, and the amazing GoPath team. Your trust, support, and hard work mean the world to us! Here’s to a festive season filled with joy, peace, and the promise of even brighter days ahead. Happy Holidays from all of us at GoPath!

This year has been packed with unforgettable moments, from celebrating with our team in the office to connecting with you all at events! 🤩 Here’s to everything we’ve accomplished and an even brighter 2025 ahead! 🚀

We sleighed our holiday lunch yesterday—no Grinch could steal these smiles! 🎅✨

A recent study led by the Desai Sethi Urology Institute sheds light on improving survival outcomes for prostate cancer patients with the adrenal-permissive HSD3B1 gene. Results from the ENZAMET trial show that adding enzalutamide or nonsteroidal antiandrogens to androgen deprivation therapy (ADT) can help overcome the poor prognosis often associated with this genetic mutation. These findings offer valuable insights into tailoring treatment strategies for advanced prostate cancer.   Read the study from the University of Miami Miller School of Medicine: https://lnkd.in/grwHy_pF

We enjoyed connecting with everyone at the AMP 2024 Annual Meeting & Expo! #AMPath24

As Thanksgiving approaches, we want to take a moment to express our gratitude. 🦃🍁 We are thankful for the healthcare community we serve and the impact we make together. Wishing you a joyful and relaxing holiday with your loved ones! Happy Thanksgiving!

Thank you to everyone who came to see us at #AMPath24! We look forward to seeing everyone in Boston next year!

We’re excited to be at the LUGPA 2024 Annual Meeting! Swing on by to learn about our genetic & genomic programs.

This November, mark Pancreatic Cancer Awareness Month with an empowering webinar hosted by the Pancreatic Cancer Action Network. On World Pancreatic Cancer Day, November 21, tune into “How Early Detection Can Change the Course for Pancreatic Cancer” to learn about early warning signs, risk factors, and advances in research shaping new approaches to detection and treatment.   Get details at https://lnkd.in/gRZpW7Dy

Join us at the 2024 LUGPA annual meeting to discover innovations that can reshape patient care in urology. Our latest genomic and genetic testing solutions offer powerful insights for targeted treatment and proactive risk management. Here’s what we’re excited to share: 🔸 PROSTATENOW: Advanced genetic testing for a precise prostate cancer risk assessment approach. 🔸 Comprehensive Genomic Solutions: From early diagnosis to tailored treatment plans, we support the unique demands of urologic care. 🔸 Clinical Integration Made Easy: Learn how to bring these genomic tools seamlessly into your practice, enhancing decision-making and patient outcomes. 🔸 OncoTarget 500: Access actionable genomic analyses on hundreds of cancer-related genes, helping you fine-tune individualized treatment options. 👉 Learn more: https://lnkd.in/gm3tY-8m